These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 19433386

  • 1. Markers of bone metabolism in women receiving aromatase inhibitors for early-stage breast cancer.
    Barginear M, Clotfelter A, Poznak CV.
    Clin Breast Cancer; 2009 May; 9(2):72-6. PubMed ID: 19433386
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of third-generation aromatase inhibitors on bone.
    McCloskey E.
    Eur J Cancer; 2006 May; 42(8):1044-51. PubMed ID: 16554149
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of aromatase inhibitors on bone metabolism].
    Folkestad L, Bjerregaard JK, Bjarnason NH, Brixen KT.
    Ugeskr Laeger; 2007 May 07; 169(19):1774-9. PubMed ID: 17537350
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of osteoporosis after breast cancer.
    Reid DM.
    Maturitas; 2009 Sep 20; 64(1):4-8. PubMed ID: 19709826
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reducing the risk of bone loss associated with breast cancer treatment.
    Hadji P.
    Breast; 2007 Dec 20; 16 Suppl 3():S10-5. PubMed ID: 18023583
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adjuvant aromatase inhibitors and bone health.
    Chowdhury S, Pickering LM, Ellis PA.
    J Br Menopause Soc; 2006 Sep 20; 12(3):97-103. PubMed ID: 16953982
    [Abstract] [Full Text] [Related]

  • 16. Novel concepts for the chemoprevention of breast cancer through aromatase inhibition.
    Kendall A, Dowsett M.
    Endocr Relat Cancer; 2006 Sep 20; 13(3):827-37. PubMed ID: 16954432
    [Abstract] [Full Text] [Related]

  • 17. Cancer treatment-induced bone loss in breast and prostate cancer.
    Saad F, Adachi JD, Brown JP, Canning LA, Gelmon KA, Josse RG, Pritchard KI.
    J Clin Oncol; 2008 Nov 20; 26(33):5465-76. PubMed ID: 18955443
    [Abstract] [Full Text] [Related]

  • 18. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G.
    Oncol Nurs Forum; 2008 Jul 20; 35(4):714-21. PubMed ID: 18591176
    [Abstract] [Full Text] [Related]

  • 19. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
    Mousa NA, Crystal P, Wolfman WL, Bedaiwy MA, Casper RF.
    Menopause; 2008 Jul 20; 15(5):875-84. PubMed ID: 18480735
    [Abstract] [Full Text] [Related]

  • 20. Aromatase inhibitor and bone.
    Miki Y, Suzuki T, Sasano H.
    Biomed Pharmacother; 2007 Oct 20; 61(9):540-2. PubMed ID: 17904790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.